New CKD biomarkers reveal tubular injury and repair pathways, enhancing personalised treatment strategies. Learn more about ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

In the phase 2 MIRO-CKD trial, 12 weeks of balcinrenone combined with dapagliflozin reduced albuminuria compared with dapagliflozin alone added to standard of care in patients with stage 3-4 CKD.

R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class therapy for chronic kidney disease (CKD) patients on dialysis with high ...

Jennifer Green, MD, provides considerations for the use of SGLT2 inhibitors in treatment of CKD. Ryan Haumschild, PharmD, MS, MBA: As we talk about SGLT2s [sodium-glucose cotransporter-2 inhibitors] ...

Chronic kidney disease (CKD) happens when your kidneys gradually lose their ability to filter waste products and excess fluid from your blood. At first, it typically causes no symptoms, but as your ...

Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm. Kidney disease is a serious yet often overlooked condition that affects millions ...

Recently analyzed evidence points to a connection between oral health and kidney health, according to work led by University ...

Kidney disease is a serious yet often overlooked condition that affects millions worldwide. Despite its impact, it is frequently underestimated compared to illnesses like cancer and heart disease. The ...